An Alternative to Remdesivir? Stanford Investigators Launch Peginterferon Lambda-1a Clinical Trial for COVID-19 Patients

An Alternative to Remdesivir? Stanford Investigators Launch Peginterferon Lambda-1a Clinical Trial for COVID-19 Patients

Stanford Medical Center launched a clinical trial using a drug called interferon-lambda, a repurposed compound already tested against viruses that cause hepatitis. The investigators have set up a special tent and will administer one dose of the investigational product...

Pin It on Pinterest